0

In Vivo Anti-Tumor Activity and Toxicological Evaluations of Perillaldehyde 8,9-Epoxide, a Derivative of Perillyl Alcohol

Luciana Nalone Andrade, Ricardo Guimarães Amaral, Grace Anne Azevedo Dória, Cecília Santos Fonseca, Tayane Kayane Mariano da Silva, Ricardo Luiz Cavalcante Albuquerque Júnior, Sara Maria Thomazzi, Lázaro Gomes do Nascimento, etc.

Int J Mol Sci. 2016 Jan 4;17(1):32.

PMID: 26742032

Abstract:

Recent studies have revealed the high cytotoxicity of p-menthane derivatives against human tumor cells. In this study, the substance perillaldehyde 8,9-epoxide, a p-menthane class derivative obtained from (S)-(-)-perillyl alcohol, was selected in order to assess antitumor activity against experimental sarcoma 180 tumors. Toxicological effects related to the liver, spleen, kidneys and hematology were evaluated in mice submitted to treatment. The tumor growth inhibition rate was 38.4%, 58.7%, 35.3%, 45.4% and 68.1% at doses of 100 and 200 mg/kg/day for perillaldehyde 8,9-epoxide, perillyl alcohol and 25 mg/kg/day for 5-FU intraperitoneal treatments, respectively. No toxicologically significant effect was found in liver and kidney parameters analyzed in Sarcoma 180-inoculated mice treated with perillaldehyde 8,9-epoxide. Histopathological analyses of the liver, spleen, and kidneys were free from any morphological changes in the organs of the animals treated with perillaldehyde 8,9-epoxide. In conclusion, the data suggest that perillaldehyde 8,9-epoxide possesses significant antitumor activity without systemic toxicity for the tested parameters. By comparison, there was no statistical difference for the antitumor activity between perillaldehyde 8,9-epoxide and perillyl alcohol.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP18031408 (S)-(−)-Perillaldehyde (S)-(−)-Perillaldehyde 18031-40-8 Price
qrcode